GlassScriptPhysician profile
Katelyn Mclane Griffin
NPI 1770012437
$2,828.67
in general payments reported to CMS, 2019-2025
32 companies · $676 in 2025
The $676 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $663 · 2022: $534 · 2023: $410 · 2024: $545 · 2025: $676.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,632.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $582.90 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $463.28 | 2021-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $250.22 | 2021-2024 | |
| Amgen INC. | $238.91 | 2021-2025 | Repatha, Repatha |
| Pfizer INC. | $195.98 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $119.61 | 2021-2025 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $109.58 | 2021-2025 | Farxiga, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $97.83 | 2023-2025 | Jardiance |
| Amarin Pharma, INC. | $84.14 | 2021 | |
| Lexicon Pharmaceuticals, INC. | $62.04 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $61.40 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.25 | 2025 | |
| Surmodics, INC. | $49.13 | 2023-2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Radial Access 018 Rx Pta Dilatation Catheter, Sublime Microcatheter, 014, 65cm, Straight |
| Edwards Lifesciences Corporation | $45.24 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Scpharmaceuticals INC. | $41.30 | 2023-2025 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $40.34 | 2025 | Octaray Mapping Catheter |
| Bridgebio Pharma, INC. | $35.23 | 2025 | Attruby |
| Amryt Pharma Holdings LTD | $31.51 | 2021 | |
| Sobi, INC | $30.88 | 2021 | |
| Abbott Laboratories | $28.50 | 2022 | |
| Esperion Therapeutics, INC. | $28.16 | 2021-2022 | |
| Genzyme Corporation | $24.83 | 2022 | |
| Bard Peripheral Vascular, INC. | $21.93 | 2025 | Venovo |
| Akcea Therapeutics, INC. | $18.40 | 2021 | |
| Atricure, INC. | $17.25 | 2025 | Atriclip Laa Exclusion System |
| Astellas Pharma US INC | $16.56 | 2021 | |
| Novo Nordisk INC | $15.50 | 2025 | Wegovy |
| Alnylam Pharmaceuticals INC. | $15.39 | 2025 | Amvuttra |
| Chiesi USA, INC. | $15.27 | 2024 | Kengreal |
| Actelion Pharmaceuticals US, INC. | $13.44 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.09 | 2025 | Lifevest |
| Vivaquant INC, Dba Rhythm Express | $6.58 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katelyn Griffin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.